Phillipsburg, NJ (Vocus) November 25, 2010
INFINITT’s 3D dental solution – Xelis Dental – has been approved by the Food & Drug Administration (FDA) in the United States.
Xelis Dental is simulation software that enables dentists and implantologists to conduct surgical planning, isolating the exact implant site and angle and determining proper sizing of the implant with precise 3D images. Since the software is used in dental offices, FDA approval is mandatory.
In October INFINITT North America won its first contract for dental PACS with Case Western Reserve. Now, with FDA approval, Xelis Dental will be officially released in the 3D dental market.
With over a decade of experience, INFINITT has provided affordable, state-of-the-art medical imaging and information capabilities to numerous Radiology, Cardiology, Orthopedics, and Dental healthcare facilities worldwide. Since the early origins of medical imaging and information technology, including Picture Archiving and Communications System (PACS), 3D Visualization, Radiology Information System (RIS), and Clinical Information System (CIS), our primary objective has been to develop the most advanced, cutting edge medical imaging and information solutions. Augmenting that objective is our strict compliance with worldwide industry standards such as DICOM, HL7, IHE, and HIPAA.
INFINITT provides its products and solutions to more than 2,000 medical facilities in 25 countries worldwide and strives to become the World’s Best Brand in the Healthcare IT industry by providing the highest levels of service, standards compliance and scalability, addressing not only today's imaging and information needs, but providing for the fully-digital enterprise of the future.
For more information, visit the INFINITT website at http://www.infinitt.com